NO20001634L - Endotelinantagonist- og <beta>-reseptor blokkerende middel som kombinertpreparater - Google Patents

Endotelinantagonist- og <beta>-reseptor blokkerende middel som kombinertpreparater

Info

Publication number
NO20001634L
NO20001634L NO20001634A NO20001634A NO20001634L NO 20001634 L NO20001634 L NO 20001634L NO 20001634 A NO20001634 A NO 20001634A NO 20001634 A NO20001634 A NO 20001634A NO 20001634 L NO20001634 L NO 20001634L
Authority
NO
Norway
Prior art keywords
beta
blocking agent
receptor blocking
endothelin antagonist
combined preparations
Prior art date
Application number
NO20001634A
Other languages
English (en)
Other versions
NO20001634D0 (no
NO319048B1 (no
Inventor
Michael Kirchengast
Klaus Muenter
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20001634L publication Critical patent/NO20001634L/no
Publication of NO20001634D0 publication Critical patent/NO20001634D0/no
Publication of NO319048B1 publication Critical patent/NO319048B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20001634A 1997-09-30 2000-03-29 Kombinasjonspreparat av endotelinantagonist og beta-reseptorblokker, fremgangsmate for fremstilling derav samt anvendelse derav for behandling av sykdommer. NO319048B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743143A DE19743143A1 (de) 1997-09-30 1997-09-30 Pharmazeutische Kombinationspräparate
PCT/EP1998/005772 WO1999016444A1 (de) 1997-09-30 1998-09-10 Endothelin-antagonist und betarezeptorenblocker als kombinationspräparate

Publications (3)

Publication Number Publication Date
NO20001634L true NO20001634L (no) 2000-03-29
NO20001634D0 NO20001634D0 (no) 2000-03-29
NO319048B1 NO319048B1 (no) 2005-06-06

Family

ID=7844115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001634A NO319048B1 (no) 1997-09-30 2000-03-29 Kombinasjonspreparat av endotelinantagonist og beta-reseptorblokker, fremgangsmate for fremstilling derav samt anvendelse derav for behandling av sykdommer.

Country Status (17)

Country Link
US (1) US6352992B1 (no)
EP (1) EP1019055B1 (no)
JP (1) JP4608093B2 (no)
KR (1) KR100623122B1 (no)
CN (1) CN1149087C (no)
AT (1) ATE239479T1 (no)
AU (1) AU739860B2 (no)
BR (1) BR9812404A (no)
CA (1) CA2304698C (no)
CZ (1) CZ298745B6 (no)
DE (2) DE19743143A1 (no)
ES (1) ES2199461T3 (no)
HK (1) HK1032355A1 (no)
HU (1) HU226745B1 (no)
NO (1) NO319048B1 (no)
RU (1) RU2213577C2 (no)
WO (1) WO1999016444A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1243262B1 (en) 2001-03-20 2006-05-31 Schwarz Pharma Ag Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
PT1243263E (pt) 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
CN1950101B (zh) 2004-04-16 2011-03-30 舒沃茨药物股份公司 肽化合物用于预防和治疗慢性头痛的用途
NZ552651A (en) 2004-08-27 2010-07-30 Sanol Arznei Schwarz Gmbh Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain
US20070196510A1 (en) * 2006-02-17 2007-08-23 Gerber Michael J Method for treating resistant hypertension
AU2007260207B2 (en) 2006-06-15 2012-11-08 Ucb Pharma Gmbh Pharmaceutical composition with synergistic anticonvulsant effect
JP2010536880A (ja) 2007-08-22 2010-12-02 ギリード・コロラド・インコーポレーテッド 糖尿病の合併症のための療法
CN104887645B (zh) * 2015-06-15 2016-12-14 吉林万通药业集团梅河药业股份有限公司 阿莫西林胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786441A (en) * 1987-08-24 1988-11-22 International Business Machines Corporation Preparation of iodonium and sulfonium triflates
SE8704081D0 (sv) * 1987-10-21 1987-10-21 Haessle Ab A new prohylactic method
ATE189217T1 (de) * 1993-03-19 2000-02-15 Merck & Co Inc Phenoxyphenylessigsäurederivate
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
MX9703988A (es) 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
PL184060B1 (pl) * 1995-01-27 2002-08-30 Rhone Poulenc Rorer Ltd Podstawione związki fenylowe do zastosowania jako środki antagonistyczne endoteliny
DE19636046A1 (de) 1996-09-05 1998-03-12 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
HUP0000553A3 (en) * 1996-12-18 2001-08-28 Abbott Gmbh & Co Kg Sixmembered nitrogencontained heteroaromatic carboxylic acid derivatives, pharmaceutical compositions containing them, and their use for producing pharmaceutical compositions

Also Published As

Publication number Publication date
RU2213577C2 (ru) 2003-10-10
CZ20001081A3 (en) 2001-05-16
EP1019055B1 (de) 2003-05-07
CN1149087C (zh) 2004-05-12
AU739860B2 (en) 2001-10-25
KR20010015650A (ko) 2001-02-26
CN1272786A (zh) 2000-11-08
HUP0004590A3 (en) 2002-01-28
CA2304698A1 (en) 1999-04-08
ES2199461T3 (es) 2004-02-16
DE59808297D1 (de) 2003-06-12
NO20001634D0 (no) 2000-03-29
DE19743143A1 (de) 1999-04-01
CA2304698C (en) 2008-02-19
HK1032355A1 (en) 2001-07-20
CZ298745B6 (cs) 2008-01-16
US6352992B1 (en) 2002-03-05
EP1019055A1 (de) 2000-07-19
AU9267298A (en) 1999-04-23
JP2001517703A (ja) 2001-10-09
NO319048B1 (no) 2005-06-06
BR9812404A (pt) 2000-09-19
ATE239479T1 (de) 2003-05-15
HU226745B1 (en) 2009-09-28
HUP0004590A2 (hu) 2001-11-28
WO1999016444A1 (de) 1999-04-08
KR100623122B1 (ko) 2006-09-12
JP4608093B2 (ja) 2011-01-05

Similar Documents

Publication Publication Date Title
DE60220441D1 (de) Substituierte phenylpropionsäurederivate als agonisten des menschlichen peroxisom-proliferator-aktiverten rezeptors alpha(ppar)
NO994177D0 (no) Atropisomere av 3-aryl-4(3H)-kinazoloner og deres anvendelse som AMPA-reseptor-antagonister
DK0856001T3 (da) Pyrimidinderivater som 5-HT2C-receptor-antagonister
ATE245960T1 (de) Dünne,komfortable,interlabiale absorbierende struktur
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
TR199501387A2 (tr) Alfa1-adrenerjik reseptör antagonistleri olarak, yeni £3-(4-fenilpiperazin-1-il) propilamino|-piridin, pirimidin ve benzen türevleri.
NO20001634L (no) Endotelinantagonist- og &lt;beta&gt;-reseptor blokkerende middel som kombinertpreparater
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DE69320985T2 (de) Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
DK1468689T3 (da) 2-methyl-thieno-benzodiazepine formulation
IT1293910B1 (it) Bracciolo di sedia, e sedia utilizzante tale bracciolo.
BR9815335A (pt) Uso de antagonistas de receptor de endotelina.
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
NO996268L (no) Nye &lt;beta&gt;-amino- og &lt;beta&gt;-azidokarboksylsyrederivater, fremstilling derav og anvendelse derav som endothelinreseptorantagonister
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
NO20032415L (no) Forbindelser som er aktive på glukokortikoidreseptor II
LU90305B1 (de) Zusammenziehbare Damenbinde
NO993548D0 (no) Anvendelse av &lt;beta&gt;3-adrenergiske reseptoragonister for fremstilling av legende medikamenter
NO20021000L (no) Mesoprogestiner (progesteronreseptormodulatorer) som en komponent i preparater for hormonerstatningsterapi (HRT)
SE0004781D0 (sv) A screening assay for antagonists of human leukocyte receptors
DK0938330T3 (da) Anvendelse af LH-RH antagonister som diagnostisk middel
NO991174L (no) Anvendelse av proteiner som anti-retrovirale midler
FI963271A (fi) 2-(4-metoksifenoksi)-3-pyridiiniamiini, sen valmistus ja sen käyttö tulehduslääkkeenä
DE29506898U1 (de) Serviettenring

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE

MM1K Lapsed by not paying the annual fees